Alcon Inc.

ALC ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $10.40B $9.91B $9.46B $8.72B $8.29B $6.83B $7.51B $7.15B
Cost of Revenue $4.59B $4.33B $4.14B $3.91B $3.58B $3.83B $3.72B $3.96B
Gross Profit $5.75B $5.51B $5.25B $4.75B $4.65B $2.94B $3.66B $3.19B
Gross Margin 55.2% 55.6% 55.5% 54.5% 56.1% 43.0% 48.8% 44.6%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense — — — — — — — —
Operating Income $1.36B $1.41B $1.04B $672.0M $580.0M $-482.0M $-187.0M $-248.0M
Operating Margin 13.1% 14.3% 11.0% 7.7% 7.0% -7.1% -2.5% -3.5%
Interest Expense $204.0M $192.0M $189.0M $134.0M $120.0M $124.0M $113.0M $24.0M
Pretax Income $1.16B $1.26B $832.0M $463.0M $418.0M $-635.0M $-332.0M $-300.0M
Income Tax Expense $180.0M $238.0M $-142.0M $128.0M $42.0M $-104.0M $324.0M $-73.0M
Net Income $980.0M $1.02B $974.0M $335.0M $376.0M $-531.0M $-656.0M $-227.0M
Net Margin 9.4% 10.3% 10.3% 3.8% 4.5% -7.8% -8.7% -3.2%
EPS (Basic) $1.99 $2.06 $1.98 $0.68 $0.77 $-1.09 $-1.34 $-0.46
EPS (Diluted) $1.98 $2.05 $1.96 $0.68 $0.76 $-1.09 $-1.34 $-0.46
Shares Outstanding (Basic) 487.4M 494.6M 493.2M 490.1M 490.1M 489.2M 488.3M —
Shares Outstanding (Diluted) 487.4M 494.6M 493.2M 490.1M 490.1M 489.2M 488.3M —
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →